Alar Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,837	1,406	739.46	455.35	519.07	560.96
Short-Term Investments	502.9	1,025	156.53	30.87	-	-
Cash & Short-Term Investments	2,339	2,431	895.99	486.22	519.07	560.96
Cash Growth	-3.50%	171.32%	84.28%	-6.33%	-7.47%	227.56%
Receivables	-	-	-	0.84	-	-
Prepaid Expenses	28.48	2	3.56	9.96	9.62	7.7
Other Current Assets	10.9	8.58	3.47	0.55	0.01	22.76
Total Current Assets	2,379	2,442	903.02	497.57	528.69	591.42
Property, Plant & Equipment	16.64	13.58	12.77	9.78	9.1	7.75
Long-Term Investments	60.46	21.46	-	-	-	-
Long-Term Deferred Tax Assets	58.95	48.27	54.97	13	-	-
Other Long-Term Assets	0.6	31.2	2.45	2.25	2.11	4.8
Total Assets	2,516	2,556	973.21	522.6	539.91	603.98
Accrued Expenses	36.25	6.69	20.48	2.02	2.17	2
Current Portion of Leases	3.55	0.3	1.27	1.29	0.68	0.91
Current Income Taxes Payable	46.97	45.67	49.45	-	-	-
Current Unearned Revenue	-	1.25	1.25	-	-	-
Other Current Liabilities	3.02	1.16	2.32	2.06	1.61	1.22
Total Current Liabilities	89.79	55.08	74.77	5.37	4.46	4.13
Long-Term Leases	0.9	0.31	0.14	1.41	0.27	0.61
Long-Term Deferred Tax Liabilities	2.21	7.39	-	0.33	-	-
Other Long-Term Liabilities	1.68	1.49	1.18	0.99	0.81	0.63
Total Liabilities	94.59	64.26	76.09	8.1	5.54	5.37
Common Stock	668	668	570	570	570	570
Additional Paid-In Capital	1,579	1,579	-	-	424.04	424.04
Retained Earnings	174.15	245.09	327.12	-55.5	-459.67	-395.44
Shareholders' Equity	2,421	2,492	897.12	514.5	534.37	598.6
Total Liabilities & Equity	2,516	2,556	973.21	522.6	539.91	603.98
Total Debt	4.45	0.6	1.41	2.69	0.95	1.52
Net Cash (Debt)	2,335	2,430	894.58	483.53	518.12	559.44
Net Cash Growth	-3.67%	171.69%	85.01%	-6.68%	-7.39%	231.33%
Net Cash Per Share	34.96	36.70	15.68	8.48	9.09	11.21
Filing Date Shares Outstanding	66.8	66.8	57	57	57	57
Total Common Shares Outstanding	66.8	66.8	57	57	57	57
Working Capital	2,289	2,387	828.25	492.2	524.24	587.3
Book Value Per Share	36.24	37.30	15.74	9.03	9.37	10.50
Tangible Book Value	2,421	2,492	897.12	514.5	534.37	598.6
Tangible Book Value Per Share	36.24	37.30	15.74	9.03	9.37	10.50
Machinery	-	27.15	22.99	16.65	16.42	12.07
Leasehold Improvements	-	0.98	0.98	0.98	1.05	1.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.